HealthCor Management as of Dec. 31, 2019
Portfolio Holdings for HealthCor Management
HealthCor Management holds 56 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Laboratory Corp. of America Holdings (LH) | 5.2 | $144M | 853k | 169.17 | |
| Regeneron Pharmaceuticals (REGN) | 5.0 | $140M | 373k | 375.48 | |
| Nevro (NVRO) | 4.9 | $138M | 1.2M | 117.54 | |
| Hologic (HOLX) | 4.6 | $129M | 2.5M | 52.21 | |
| Teleflex Incorporated (TFX) | 4.2 | $117M | 310k | 376.44 | |
| Hca Holdings (HCA) | 3.9 | $109M | 737k | 147.81 | |
| Johnson & Johnson (JNJ) | 3.6 | $100M | 688k | 145.87 | |
| Madrigal Pharmaceuticals (MDGL) | 3.5 | $99M | 1.1M | 91.11 | |
| Aurinia Pharmaceuticals (AUPH) | 3.5 | $98M | 4.8M | 20.26 | |
| Medtronic (MDT) | 3.4 | $96M | 848k | 113.45 | |
| UnitedHealth (UNH) | 3.1 | $88M | 299k | 293.98 | |
| Neurocrine Biosciences (NBIX) | 3.1 | $87M | 807k | 107.49 | |
| Envista Hldgs Corp (NVST) | 3.0 | $84M | 2.8M | 29.64 | |
| Zimmer Holdings (ZBH) | 2.4 | $67M | 447k | 149.68 | |
| Intersect Ent | 2.2 | $63M | 2.5M | 24.90 | |
| Haemonetics Corporation (HAE) | 2.2 | $62M | 539k | 114.90 | |
| CONMED Corporation (CNMD) | 2.1 | $60M | 536k | 111.83 | |
| Bluebird Bio (BLUE) | 2.1 | $60M | 680k | 87.75 | |
| Becton, Dickinson and (BDX) | 2.1 | $59M | 216k | 271.97 | |
| Humana (HUM) | 2.0 | $57M | 156k | 366.52 | |
| Bristol Myers Squibb (BMY) | 1.9 | $54M | 840k | 64.19 | |
| Danaher Corporation (DHR) | 1.8 | $51M | 329k | 153.48 | |
| Intuitive Surgical (ISRG) | 1.8 | $49M | 84k | 591.15 | |
| Abiomed | 1.7 | $49M | 287k | 170.59 | |
| Merck & Co (MRK) | 1.7 | $49M | 533k | 90.95 | |
| Illumina (ILMN) | 1.7 | $48M | 146k | 331.74 | |
| Change Healthcare | 1.7 | $47M | 2.8M | 16.39 | |
| Iqvia Holdings (IQV) | 1.6 | $44M | 285k | 154.51 | |
| Axsome Therapeutics (AXSM) | 1.5 | $42M | 409k | 103.36 | |
| Viewray (VRAYQ) | 1.4 | $40M | 9.5M | 4.22 | |
| Centene Corporation (CNC) | 1.3 | $35M | 561k | 62.87 | |
| Pacira Pharmaceuticals (PCRX) | 1.2 | $35M | 771k | 45.30 | |
| Cigna Corp (CI) | 1.2 | $35M | 169k | 204.49 | |
| Amarin Corporation (AMRN) | 1.2 | $34M | 1.6M | 21.44 | |
| Agios Pharmaceuticals (AGIO) | 1.2 | $33M | 697k | 47.75 | |
| Zogenix | 1.1 | $32M | 619k | 52.13 | |
| Edwards Lifesciences (EW) | 1.1 | $31M | 133k | 233.29 | |
| Mednax (MD) | 1.1 | $30M | 1.1M | 27.79 | |
| Charles River Laboratories (CRL) | 0.9 | $27M | 175k | 152.76 | |
| Blueprint Medicines (BPMC) | 0.9 | $25M | 309k | 80.11 | |
| Gilead Sciences (GILD) | 0.7 | $18M | 284k | 64.98 | |
| Acceleron Pharma | 0.6 | $17M | 323k | 53.02 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.5 | $14M | 66k | 218.95 | |
| HMS Holdings | 0.5 | $14M | 463k | 29.60 | |
| Stryker Corporation (SYK) | 0.5 | $14M | 64k | 209.94 | |
| Eli Lilly & Co. (LLY) | 0.5 | $13M | 100k | 131.43 | |
| Health Care SPDR (XLV) | 0.4 | $10M | 100k | 101.86 | |
| Rts/bristol-myers Squibb Compa | 0.3 | $9.5M | 3.1M | 3.01 | |
| Rocket Pharmaceuticals (RCKT) | 0.3 | $8.8M | 388k | 22.76 | |
| Aerie Pharmaceuticals | 0.3 | $7.3M | 302k | 24.17 | |
| Covetrus | 0.2 | $6.6M | 500k | 13.20 | |
| Medicines Company | 0.2 | $6.4M | 75k | 84.95 | |
| Sarepta Therapeutics (SRPT) | 0.2 | $6.5M | 50k | 129.04 | |
| RTI Biologics | 0.2 | $5.9M | 2.2M | 2.74 | |
| Dermira | 0.2 | $5.5M | 364k | 15.16 | |
| Polarityte | 0.1 | $1.7M | 636k | 2.60 |
